Abstract
Basal cell carcinoma (BCC) is the most common type of skin cancer and the incidence of BCC is expected to rise, with increased demand on dermatology resources. Little is known of the effect on people's lives of having skin cancer. The aim of this study was to quantify the handicap caused by basal cell carcinomas before and after therapy. Forty-four patients (22 males, mean age = 65 yrs, range = 35–81 yrs) with 48 BCCs were recruited and 37 patients completed the study. Each patient completed the UK Sickness Impact Profile (UKSIP) and the Dermatology Life Quality Index (DLQI) at the initial visit to the dermatology clinic, 1 week after treatment and 3 months after treatment. Lesions had been present for a mean of 25 months (range = 1–240 months), their mean diameter was 9.6mm (range = 3–35mm) and the sites were head and neck (79%), trunk (17%) and limbs (4%). There was no relationship between the quality of life score and size of lesion. Overall the scores at presentation were very low, rising 1 week after treatment and falling to below the initial scores at 3 months (mean UKSIP 0.4%, 0.7%, 0.13%; mean DLQI 5.3% 8.7%, 1.2%). BCCs cause little handicap. This may explain the delay in seeking medical attention and should be considered in planning public health education about BCCs.
Similar content being viewed by others
References
Finlay AY, Kahn GK, Luscombe DK, Salek MS. Validation of Sickness Impact Profile and Psoriasis Disability Index in psoriasis. Brit J Derm 1990; 123: 751–756.
Motley RJ, Finlay AY. Practical use of a disability index in the routine management of acne. Clin Exp Derma 1992; 17: 1–3.
Roberts DL. Non-melanoma skin cancer in West Glamorgan. Brit J Derm 1990; 122: 399–403.
Finlay AY, Kahn GK. Dermatology Life Quality Index (DLQI): A simple practical measure for routine clinical use. Clin Exp Derm 1994; 19: 210–216.
Salek MS, Luscombe DK, Walker SR, et al. Quality of life assessment in patients with angina using the sickness impact profile (SIP). Brit J Clin Pharma 1988; 25: 99–100.
Salek MS, Finlay AY, Luscombe DK, et al. Cyclosporin greatly improves the quality of life of adults with severe atopic dermatitis. Brit J Derm 1993; 129: 422–430.
Sigurdardottir V, Bolund C, Brandberg Y, Sullivan M. The impact of generalized malignant melanoma on quality of life evaluated by the EORTC questionnaire technique. Qual Life Res 1993; 2: 193–203.
Holfeld KI, Hogan DJ, Eldemire M, et al. A psychosocial assessment of patients with basal cell carcinoma. J Derma Surg Oncol 1990; 16(8): 750–753.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Blackford, S., Roberts, D., Salek, M.S. et al. Basal cell carcinomas cause little handicap. Qual Life Res 5, 191–194 (1996). https://doi.org/10.1007/BF00434740
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00434740